Does cost-effectiveness of influenza vaccine choice vary across the U.S.? An agent-based modeling study.

ABSTRACT:

Background

In a prior agent-based modeling study, offering a choice of influenza vaccine type was shown to be cost-effective when the simulated population represented the large, Washington DC metropolitan area. This study calculated the public health impact and cost-effectiveness of the same four strategies: No Choice, Pediatric Choice, Adult Choice, or Choice for Both Age Groups in five United States (U.S.) counties selected to represent extremes in population age distribution.

Methods

The choice offered was either inactivated influenza vaccine delivered intramuscularly with a needle (IIV-IM) or an age-appropriate needle-sparing vaccine, specifically, the nasal spray (LAIV) or intradermal (IIV-ID) delivery system. Using agent-based modeling, individuals were simulated as th

SUBMITTER: DePasse JV 

PROVIDER: S-EPMC5808929 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature